High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas

Annals of Surgical Oncology

Volumn 15, Issue 8, 2008, Pages 2318-2328

  Ouaïssi, Mehdi ^a,b,c,d   Sielezneff, Igor ^a,b   Silvestre, Ricardo ^d,e   Sastre, Bernard ^a,b   Bernard, Jean Paul ^b,c   Lafontaine, Joelle Simony ^g   Payan, Marie José ^a   Dahan, Laetitia ^a,b   Pirrò, Nicolas ^a,b   Seitz, Jean François ^a,b   Mas, Eric ^c   Lombardo, Dominique ^c   Ouaissi, Ali ^d,e,f  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c University of the Mediterranean Aix Marseille II   (France)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^e UNIVERSITY OF PORTO   (Portugal)

^f INSERM   (France)

^g CENTRE VAL D AURELLE   (France)

Author keywords

Gene expression; HDACs; Pancreatic tumors; qPCR; RT PCR; SIRTs

Indexed keywords

HISTONE DEACETYLASE 7; MESSENGER RNA;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CYSTADENOMA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LIVER TRANSPLANTATION; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE SECTION; WESTERN BLOTTING;

EID: 48149115853     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9940-z     Document Type: Article

References (42)

1. RT Greenlee T Murray S Bolden 2000 Cancer statistics Cancer J Clin 50 7 33
2. M Goggins M Canto R Hruban 2000 Can we screen high-risk individuals to detect early pancreatic carcinoma? J Surg Oncol 74 243 8
3. L Rosenberg 2000 Pancreatic cancer: a review of emerging therapies Drugs 59 1071 89
4. B Gerdes A Ramaswamy A Ziegler 2002 p16INK4a is a prognostic marker in resected ductal pancreatic cancer Ann Surg 235 51 9
5. WD Cress E Seto 2000 Histone deacetylase, transcriptional control and cancer J Cell Physiol 184 1 16
6. PA Marks 2001 Histone deacetylase inhibitors as a new drugs Curr Opin Oncol 13 477 83
7. S Timmermann 2001 Histone acetylation and disease Cell Mol Life Sci 58 728 36
8. AT Amunziato JC Hansen 2000 Role of histone acetylation in the assembly and modulation of chromatin structures Gene Expr 9 37 61
9. JE Bolden MJ Peart RW Johnstone 2006 Anticancer activities of histone deacetylase inhibitors Nat Rev Drug Discov 5 769 84
10. RA Frye 2000 Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins Biochem Biophys Res Commun 273 793 8
11. F De Nigris J Cerutti C Morelli 2002 Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues Br J Cancer 86 917 23
12. Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Handbook, 6th edition. American Joint Committee on Cancer. New York: Springer Verlag, 2002
13. F Corpet 1988 Multiple sequence alignment with hierarchical clustering Nucl Acids Res 22 10881 90
14. -ΔΔCt method Methods 25 402 8
15. AM Avila BG Burnett AA Taye 2007 Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy J Clin Inv 117 659 71
16. S Shen J Li P Casaccia-Bonnefil 2005 Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing brain J Cell Biol 169 577 88
17. TM Gress F Muller-Pillasch M Geng 1996 A pancreatic cancer-specific expression profile Oncogene 13 1819 30
18. T Crnogorac-Jurcevic E Efthimiou P Capelli 2001 Gene expression profiles of pancreatic cancer and stromal desmoplasia Oncogene 20 7437 46
19. D Sidransky 2002 Emerging molecular markers of cancer Nat Rev Cancer 2 210 9
20. C Rosty M Goggind 2002 Early detection of pancreatic carcinoma Hematol Oncol Clin North Am 16 37 52
21. H Suzuki E Gabrielson W Chen 2002 A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer Nat Genet 31 141 9
22. CA Iacobuzio-Donahue A Ashfaq A Maitra 2003 Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies Cancer Res 63 8614 22
23. N Bardeey RA DePinho 2002 Pancreatic cancer biology and genetics Nat Rev Cancer 2 897 909
24. T Crnogorac-Jurcevic E Missiaglia E Blaveri 2003 Molecular alterations in pancreatic carcinoma expression profiling shows that dysregulated expression of S100 genes is highly prevalent J Pathol 201 63 74
25. A Shekouh CC Thompson W Prime 2003 Development and application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma Proteomics 3 1988 2001
26. D Vimalachandran W Greenhalf C Thompson 2005 High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients Cancer Res 65 3218 25
27. RH Hruban C Iacobuzio-Donahue RE Wilentz 2001 Molecular pathology of pancreatic cancer Cancer J 7 251 8
28. M Ebert M Yokoyama H Friess 1995 Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer Int J Cancer 62 529 35
29. H Friess Y Yamanaka M Büchler 1993 Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression Cancer Res 53 2704 7
30. JH Choi HJ Kwon BI Yoon 2001 Expression profile of histone deacetylase 1 in gastric cancer tissues Jpn J Cancer Res 92 1300 4
31. P Zhu E Martin J Mengwasser P Schlag 2004 Induction of HDAC2 expression upon loss of APC in colorectal tumorogenesis Cancer Cell 5 455 63
32. AJ Wilson DS Byun N Popova 2006 Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer J Biol Chem 281 13548 58
33. MJ Scanlan S Welt CM Gordon 2002 Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets Cancer Res 62 4041 7
34. M Hiratsuka T Inoue T Toda 2003 Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene Biochem Biophys Res Commun 309 558 66
35. M Ouaissi A Ouaissi 2006 Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases J Biomed Biotechnol 13474 1 10
36. PA Marks R Breslow 2007 Dimethyl sulfoxide to vorinostat: development of the histone deacetylase inhibitor as an anticancer drug Nat Biotechnol 25 84 90
37. M Dokmanovic G Perez W Xu 2007 Histone deacetylase inhibitors selectively suppress expression of HDAC7 Mol Cancer Ther 6 2525 34
38. D Mottet A Bellahcène S Pirotte 2007 HDAC7 silencing alters endothelial cell migration, a key step in angiogenesis Cir Res 18 1794 801
39. F Dequiedt H Kasler W Fischle 2003 HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis Immunity 18 687 98
40. HY Kao A Verdel CC Tsai 2001 Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7 J Biol Chem 276 47496 507
41. M Parra H Kasler TA McKinsey 2005 Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation J Biol Chem 280 13762 70
42. S Sener A Frengen HR Menck 1999 Pancreatic cancer: a report of treatment and survival trends for 100313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1 7